PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
40.52%
Revenue growth above 1.5x RUN's 7.63%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-124.82%
Negative gross profit growth while RUN is at 8.57%. Joel Greenblatt would examine cost competitiveness or demand decline.
-481.19%
Negative EBIT growth while RUN is at 4.71%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-2818.90%
Negative operating income growth while RUN is at 4.71%. Joel Greenblatt would press for urgent turnaround measures.
-578.55%
Negative net income growth while RUN stands at 72.01%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-586.21%
Negative EPS growth while RUN is at 75.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-586.21%
Negative diluted EPS growth while RUN is at 75.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.17%
Share reduction more than 1.5x RUN's 0.78%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.17%
Slight or no buyback while RUN is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
478.71%
OCF growth above 1.5x RUN's 18.98%. David Dodd would confirm a clear edge in underlying cash generation.
293.13%
FCF growth above 1.5x RUN's 2.65%. David Dodd would verify if the firm’s strategic investments yield superior returns.
554.41%
10Y revenue/share CAGR above 1.5x RUN's 53.56%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
28.41%
5Y revenue/share CAGR at 50-75% of RUN's 53.56%. Martin Whitman would worry about a lagging mid-term growth trajectory.
40.91%
3Y revenue/share CAGR at 75-90% of RUN's 53.56%. Bill Ackman would expect new product strategies to close the gap.
643.25%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
156.27%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
1197.14%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
-1257.38%
Negative 10Y net income/share CAGR while RUN is at 183.32%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-133.75%
Negative 5Y net income/share CAGR while RUN is 183.32%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1180.57%
Negative 3Y CAGR while RUN is 183.32%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-1.90%
Negative equity/share CAGR over 10 years while RUN stands at 58.65%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-44.19%
Negative 5Y equity/share growth while RUN is at 58.65%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-20.78%
Negative 3Y equity/share growth while RUN is at 58.65%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.07%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-10.16%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-10.39%
Negative asset growth while RUN invests at 6.46%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-16.78%
We have a declining book value while RUN shows 5.79%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-28.73%
We’re deleveraging while RUN stands at 8.05%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-15.25%
Our R&D shrinks while RUN invests at 18.19%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-16.93%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94